The association of lipodystrophy and oxidative stress biomarkers in HIV-infected men

Current HIV Research

Volumn 8, Issue 5, 2010, Pages 364-369

  Vassimon, Helena S ^a   Deminice, Rafael ^a   Machado, Alcyone A ^a   Monteiro, Jacqueline P ^b   Jordao, Alceu A ^a  

^a Department of Internal Medicine ^*  (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Free radicals; HIV; Hydroperoxide; Insulin; Lipodystrophy; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; ANTIVIRUS AGENT; BIOLOGICAL MARKER; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; HYDROPEROXIDE; INSULIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INSULIN BLOOD LEVEL; LIPID OXIDATION; LIPODYSTROPHY; MALE; METABOLISM; OBSERVATIONAL STUDY; OXIDATIVE STRESS; TREATMENT DURATION; WEIGHT GAIN;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; HYDROGEN PEROXIDE; INSULIN; MALE; MIDDLE AGED; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 77954743512     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210791330347     Document Type: Article

References (26)

1. Pere D, Ignacio SL, Ramon T, et al. Dyslipidemia andCardiovascular Disease Risk Factor Management in HIV-1-Infected Subjects Treated with HAART in the Spanish VACHCohort. Open AIDS J 2008; 2: 26-38.
2. Aboud M, Elgalib A, Kulasegaram R, Peters B. Insulin resistanceand HIV infection: a review. Int J Clin Pract 2007; 61: 463-72.
3. Masia M, Padilla S, Bernal E, et al. Influence of antiretroviraltherapy on oxidative stress and cardiovascular risk: a prospectivecross-sectional study in HIV-infected patients. Clin Ther 2007; 29:1448-55.
4. Baril JG, Junod P, Leblanc R, et al. HIV-associated lipodystrophysyndrome: A review of clinical aspects. Can J Infect Dis MedMicrobiol 2005; 16: 233-43.
5. Aghdassi E, Arendt B, Salit IE, Allard JP. Estimation of body fatmass using dual-energy x-ray absorptiometry, bioelectricimpedance analysis, and anthropometry in HIV-positive malesubjects receiving highly active antiretroviral therapy. JPEN JParenter Enteral Nutr 2007; 31: 135-41.
6. Capeau J. From lipodystrophy and insulin resistance to metabolicsyndrome: HIV infection, treatment and aging. Curr Opin HIVAIDS 2007; 2: 247-52.
7. Skvarilova M, Bulava A, Stejskal D, Adamovska S, Bartek J.Increased level of advanced oxidation products (AOPP) as amarker of oxidative stress in patients with acute coronarysyndrome. Biomed Pap Med Fac Univ Palacky Olomouc CzechRepub 2005; 149: 83-7.
8. Turchan J, Pocernich CB, Gairola C, et al. Oxidative stress in HIVdemented patients and protection ex vivo with novel antioxidants.Neurology 2003; 60: 307-14.
9. Ngondi JL, Oben J, Forkah DM, Etame LH, Mbanya D. The effectof different combination therapies on oxidative stress markers inHIV infected patients in Cameroon. AIDS Res Ther 2006; 3: 19.
10. Aukrust P, Luna L, Ueland T, et al. Impaired base excision repairand accumulation of oxidative base lesions in CD4+ T cells ofHIV-infected patients. Blood 2005; 105: 4730-5.
11. Tang AM, Smit E. Oxidative stress in HIV-1-infected injectiondrug users. J Acquir Immune Defic Syndr 2000; 25(Suppl 1): S12-18.
12. McComsey GA, Morrow JD. Lipid oxidative markers aresignificantly increased in lipoatrophy but not in sustainedasymptomatic hyperlactatemia. J Acquir Immune Defic Syndr 2003; 34: 45-9.
13. Sutinen J, Yki-Jarvinen H. Increased resting energy expenditure,fat oxidation, and food intake in patients with highly activeantiretroviral therapy-associated lipodystrophy. Am J PhysiolEndocrinol Metab 2007; 292: E687-692.
14. Costa CMDS, Lima, E. A simple automated procedure for thiolmeasurement in human and serum samples. Braz J Pathol Lab Med 2006; 42: 345-50.
15. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al.Advanced oxidation protein products as a novel marker ofoxidative stress in uremia. Kidney Int 1996; 49: 1304-13.
16. Sodergren E, Nourooz-Zadeh J, Berglund L, Vessby B. Re-evaluation of the ferrous oxidation in xylenol orange assay for themeasurement of plasma lipid hydroperoxides. J Biochem BiophysMethods 1998; 37: 137-46.
17. Jordao AA, Jr., Chiarello PG, Arantes MR, Meirelles MS,Vannucchi H. Effect of an acute dose of ethanol on lipidperoxidation in rats: action of vitamin E. Food Chem Toxicol 2004;42: 459-64.
18. Caron M, Vigouroux C, Bastard JP, Capeau J. Adipocytedysfunction in response to antiretroviral therapy: clinical, tissueand in-vitro studies. Curr Opin HIV AIDS 2007; 2: 268-73.
19. Lewis W, Day BJ, Copeland WC. Mitochondrial toxicity of NRTIantiviral drugs: an integrated cellular perspective. Nat Rev DrugDiscov 2003; 2: 812-22.
20. Ando K, Fujita T. Metabolic syndrome and oxidative stress. FreeRadic Biol Med 2009; 47: 213-8.
21. Park K, Gross M, Lee DH, et al. Oxidative stress and insulinresistance: the coronary artery risk development in young adultsstudy. Diabetes Care 2009; 32: 1302-7.
22. Davi G, Falco A, Patrono C. Lipid peroxidation in diabetesmellitus. Antioxid Redox Signal 2005; 7: 256-68.
23. Heilbronn L, Smith SR, Ravussin E. Failure of fat cellproliferation, mitochondrial function and fat oxidation results inectopic fat storage, insulin resistance and type II diabetes mellitus.Int J Obes Relat Metab Disord 2004; 28(Suppl 4): S12-21.
24. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome.Life Sci 2009; 84: 705-12.
25. Allard JP, Aghdassi E, Chau J, et al. Effects of vitamin E and Csupplementation on oxidative stress and viral load in HIV-infectedsubjects. AIDS 1998; 12: 1653-9.
26. Cangemi R, Loffredo L, Carnevale R, et al. Early decrease ofoxidative stress by atorvastatin in hypercholesterolaemic patients:effect on circulating vitamin E. Eur Heart J 2008; 29: 54-62.